We demonstrated the efficacy of ZQD treatment in reducing prostate cancer cells proliferation and tumor growth, evidenced by inhibiting the activation of IL-6/STAT3 signaling pathway in vitro (PC3 and DU145 cells) and xenograft tumor model in vivo. This evidence concerns the gene STAT3 and prostate carcinoma.